Abstract | OBJECTIVES: METHODS: RESULTS: No radiotherapy interruptions, no hospitalisation due to toxic reactions, and no severe toxicity were observed. Six patients (50%) had pain control without pharmacological therapy, three patients (25%) reduced their use (35%-72%) of analgesics, while in the remaining three patients (25%) there was no change in analgesic use. Overall, mean reduction in the use of analgesics was 63.1% +/- 43.8%. During follow-up (44 months), two patients (16.7%) showed a worsening of pain that required increased analgesia; in one patient, percutaneous splanchnicectomy was necessary. CONCLUSION: In patients excluded from standard concomitant chemoradiation, hypofractionated-accelerated radiotherapy is feasible and results in pain relief in most patients, documented as a reduced need for analgesics.
|
Authors | Alessio G Morganti, Lucio Trodella, Vincenzo Valentini, Sergio Barbi, Gabriella Macchia, Giovanna Mantini, Adriana Turriziani, Numa Cellini |
Journal | Journal of palliative care
(J Palliat Care)
Vol. 19
Issue 4
Pg. 258-62
( 2003)
ISSN: 0825-8597 [Print] United States |
PMID | 14959596
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Actuarial Analysis
- Adult
- Aged
- Aged, 80 and over
- Analgesia
(methods)
- Analgesics
(therapeutic use)
- Combined Modality Therapy
- Dose Fractionation, Radiation
- Feasibility Studies
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Pain
(diagnosis, etiology, prevention & control)
- Pain Measurement
- Palliative Care
(methods)
- Pancreatic Neoplasms
(complications, mortality, radiotherapy)
- Radiotherapy Dosage
- Survival Analysis
- Treatment Outcome
|